Imaging and Pathological Markers for Metastatic Brain Tumors
A special issue of Brain Sciences (ISSN 2076-3425). This special issue belongs to the section "Neuro-oncology".
Deadline for manuscript submissions: closed (24 March 2022) | Viewed by 5952
Special Issue Editors
2. Department of Radiology, Emergency County Hospital, Cluj-Napoca, Romania
3. Department of Interventional Radiology, Emergency County Hospital, Târgu Mureș, Romania
Interests: neuroimaging; MRI; texture analysis; computer-aided diagnosis; radiomics
Special Issues, Collections and Topics in MDPI journals
Interests: neuropathology; brain tumors; molecular markers; differential diagnosis; prognostic and predictive factors
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Secondary brain tumors (metastasis) affect up to one third of oncological patients, representing a major cause of systemic morbidity and mortality. The incidence of brain metastasis is increasing, likely due to improved imaging detection of small lesions and advanced management of extracerebral disease.
The imaging differentiation between brain metastases and other pathologies such as primary tumors, demyelinating lesions, infections, infarction, and hemorrhage can strongly influence the clinical outcome. However, classic magnetic resonance (MRI) brain sequences can prove to be insufficient to certify diagnosis. Radiomics and Artificial Intelligence applications on one hand and advanced MRI techniques on the other (such as magnetic resonance spectroscopy, quantitative magnetization transfer, TRANS-membrane water exchange, chemical exchange saturation transfer MRI, perfusion imaging, etc.) can have an important role in tumor detection, differentiating malignancy types, evaluating treatment response, and even predicting survival. In order to highlight more accurately the importance of the new imaging methods in brain metastases detection and differential diagnosis, histopathological analysis will be taken into account, focusing on new molecular markers determined by both genetics and immuhistochemistry.
This Special Issue will highlight advances in brain metastases imaging, with a focus on radiomics, AI applications, quantitative imaging, and advanced MRI sequences. Manuscripts that investigate new modalities of the histopathological diagnosis of brain metastases are also welcomed.
Dr. Paul-Andrei Ștefan
Guest Editor
Dr. Sergiu Șușman
Co-Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Brain Sciences is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- brain metastases
- glioma
- MRI
- radiomics
- pathology
- texture analysis
